Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2015, Article ID 970289, 4 pages
http://dx.doi.org/10.1155/2015/970289
Case Report

Sometimes There Is More Than One Puzzle on the Table: Pneumococcal Bacteremia as a New Systemic Lupus Erythematosus Presentation

1Department of Infectious Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad 91388-13944, Iran
2Department of Rheumatology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad 91388-13944, Iran

Received 12 October 2015; Accepted 9 December 2015

Academic Editor: Larry M. Bush

Copyright © 2015 Fereshte Sheybani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. B. Greenberg, “Infections in the immunocompromised rheumatologic patient,” Critical Care Clinics, vol. 18, no. 4, pp. 931–956, 2002. View at Publisher · View at Google Scholar
  2. D. B. Hellmann, M. Petri, and Q. Whiting-O'Keefe, “Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms,” Medicine, vol. 66, no. 5, pp. 341–348, 1987. View at Google Scholar · View at Scopus
  3. M. Yurkovich, K. Vostretsova, W. Chen, and J. A. Aviña-Zubieta, “Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies,” Arthritis Care and Research, vol. 66, no. 4, pp. 608–616, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. P. H. Schur and D. D. Gladman, “Overview of the clinical manifestations of systemic lupus erythematosus in adults,” in Up to Date, D. S. Basow, Ed., UpToDate, Waltham, Mass, USA, 2011. View at Google Scholar
  5. S. Janwityanuchit, K. Totemchokchyakarn, K. Krachangwongchai, and M. Vatanasuk, “Infection in systemic lupus erythematosus,” Journal of the Medical Association of Thailand, vol. 76, no. 10, pp. 542–548, 1993. View at Google Scholar · View at Scopus
  6. N. I. Paton, “Infections in systemic lupus erythematosus patients,” Annals of the Academy of Medicine, Singapore, vol. 26, no. 5, pp. 694–700, 1997. View at Google Scholar
  7. B. J. Fessler, “Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis,” Best Practice & Research Clinical Rheumatology, vol. 16, no. 2, pp. 281–291, 2002. View at Google Scholar
  8. M. K. Shaughnessy, D. N. Williams, and B. Segal, “Severe infection with encapsulated bacteria as the initial presentation of systemic lupus erythematosus: two case reports and a review of the literature,” JMM Case Reports, 2014. View at Publisher · View at Google Scholar
  9. D. Santilli, M. Govoni, N. Prandini, N. Rizzo, and F. Trotta, “Autosplenectomy and antiphospholipid antibodies in systemic lupus erythematosus: a pathogenetic relationship?” Seminars in Arthritis and Rheumatism, vol. 33, no. 2, pp. 125–133, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Petros and S. West, “Overwhelming pneumococcal bacteraemia in systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 48, no. 4, pp. 333–335, 1989. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Zandman-Goddard and Y. Shoenfeld, “Infections and SLE,” Autoimmunity, vol. 38, no. 7, pp. 473–485, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. C.-L. Hsu, K.-Y. Chen, P.-S. Yeh et al., “Outcome and prognostic factors in critically ill patients with systemic lupus erythematosus: a retrospective study,” Critical Care, vol. 9, no. 3, pp. R177–R183, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Petri, “Infection in systemic lupus erythematosus,” Rheumatic Disease Clinics of North America, vol. 24, no. 2, pp. 423–456, 1998. View at Google Scholar
  14. J. A. Elliott, A. Copeman, and K. Davies, “Pneumococcal sepsis as the first presentation of systemic lupus erythematosus (SLE) in a six year old boy,” Archives of Disease in Childhood, vol. 96, supplement 1, p. A78, 2011. View at Publisher · View at Google Scholar
  15. B. Segal, D. N. Williams, and M. K. Shaughnessy, “Severe infection with encapsulated bacteria as the initial presentation of systemic lupus erythematosus: two case reports and a review of the literature,” JMM Case Reports, vol. 1, no. 2, 2014. View at Publisher · View at Google Scholar
  16. H. Tomita, M. Yamada, I. Sekigawa, T. Yoshiike, N. Iida, and H. Hashimoto, “Systemic lupus erythematosus-like autoimmune abnormalities induced by bacterial infection,” Clinical and Experimental Rheumatology, vol. 21, no. 4, pp. 497–499, 2003. View at Google Scholar · View at Scopus
  17. S. Charuvanij and K. M. Houghton, “Acute epiglottitis as the initial presentation of pediatric Systemic Lupus Erythematosus,” Pediatric Rheumatology, vol. 7, article 19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Firooz, D. A. Albert, D. J. Wallace, M. Ishimori, D. Berel, and M. H. Weisman, “High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus,” Lupus, vol. 20, no. 6, pp. 588–597, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Quintana, Y. F. Medina, C. Rojas et al., “The use of procalcitonin determinations in evaluation of systemic lupus erythematosus,” Journal of Clinical Rheumatology, vol. 14, no. 3, pp. 138–142, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. K. M. Bador, S. Intan, S. Hussin, and A. H. Gafor, “Serum procalcitonin has negative predictive value for bacterial infection in active systemic lupus erythematosus,” Lupus, vol. 21, no. 11, pp. 1172–1177, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Serio, L. Arnaud, A. Mathian, P. Hausfater, and Z. Amoura, “Can procalcitonin be used to distinguish between disease flare and infection in patients with systemic lupus erythematosus: a systematic literature review,” Clinical Rheumatology, vol. 33, no. 9, pp. 1209–1215, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Buhaescu, R. A. Yood, and H. Izzedine, “Serum procalcitonin in systemic autoimmune diseases—where are we now?” Seminars in Arthritis and Rheumatism, vol. 40, no. 2, pp. 176–183, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. S. R. Mitchell, P. Q. Nguyen, and P. Katz, “Increased risk of neisserial infections in systemic lupus erythematosus,” Seminars in Arthritis & Rheumatism, vol. 20, no. 3, pp. 174–184, 1990. View at Publisher · View at Google Scholar · View at Scopus
  24. O. Elkayam, D. Paran, D. Caspi et al., “Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus,” Clinical Infectious Diseases, vol. 34, no. 2, pp. 147–153, 2002. View at Publisher · View at Google Scholar · View at Scopus